SUMMIT THERAPEUTICS INCSUMMIT THERAPEUTICS INCSUMMIT THERAPEUTICS INC

SUMMIT THERAPEUTICS INC

No trades
See on Supercharts

Price target

671.650.000.00%
The 6 analysts offering 1 year price forecasts for SMMT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to SMMT in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SMMT EPS for the last quarter is −0.99 MXN despite the estimation of −1.32 MXN. In the next quarter EPS is expected to reach −1.61 MXN. Track more of SUMMIT THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter SUMMIT THERAPEUTICS INC revenue is expected to reach 0.00 MXN. Check out SUMMIT THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, SMMT price target is 671.65 MXN with a max estimate of 886.58 MXN and a min estimate of 463.44 MXN. Check if this forecast comes true in a year, meanwhile watch SUMMIT THERAPEUTICS INC stock price chart and keep track of the current situation with SMMT news and stock market news.
We've gathered opinions of 6 analysts rating SMMT stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.